Antibody-Drug Conjugates (ADCs) Market: Targeted Cancer Therapy...

ha aggiunto una foto Altre informazioni

2025-05-12 06:21:07 -

Antibody-Drug Conjugates (ADCs) Market: Targeted Cancer Therapy Revolution

Market Overview The global antibody-drug conjugates (ADCs) market is projected to grow from 8.2billion in 2023 to 8.2 billion in 2023 to 32.5 billion by 2032, at a 16.8% CAGR, driven by oncology innovation and improved targeting technologies. ADCs now represent 25% of the late-stage oncology pipeline, with 12+ FDA...

0 Commenti 0 condivisioni 597 Views 0 Anteprima